BioStem Technologies (BioStem Technologies) Accounts Payable & Accrued Expense : $2.94 Mil (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies Accounts Payable & Accrued Expense?

BioStem Technologies's quarterly accounts payable & accrued expense increased from Dec. 2022 ($2.05 Mil) to Mar. 2023 ($2.38 Mil) and increased from Mar. 2023 ($2.38 Mil) to Sep. 2023 ($2.94 Mil).

BioStem Technologies's annual accounts payable & accrued expense increased from Dec. 2020 ($2.48 Mil) to Dec. 2021 ($3.12 Mil) but then declined from Dec. 2021 ($3.12 Mil) to Dec. 2022 ($2.05 Mil).

BioStem Technologies Accounts Payable & Accrued Expense Historical Data

The historical data trend for BioStem Technologies's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioStem Technologies Accounts Payable & Accrued Expense Chart

BioStem Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.77

1.82

2.48

3.12

2.05

BioStem Technologies Quarterly Data
	Sep15	Dec15	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Dec21	Mar22	Sep22	Dec22	Mar23	Sep23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															-	-	2.05	2.38	2.94

BioStem Technologies Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

BioStem Technologies (BioStem Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2836 Center Port Circle, Pompano Beach, FL, USA, 33064

Website

https://www.biostemtechnologies.com

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.